Fig. 5From: Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosisSurvival analysis of clinical subgroups of patients. a–k: Kaplan–Meier curves and the log-rank test showed that the overall survival of the high-risk set was significantly worse than that of the low-risk set in these 11 subgroups of patients (a–k)Back to article page